23-25 June in San Diego, USA
Trailblazing immunotherapies to transform the oncology and autoimmune landscapes.
As the industry’s most comprehensive end-to-end forum dedicated to advancing, optimizing, and translating T cell engagers, the 8th T Cell Engager Therapeutics Summit spotlights the next frontier of TCE science. Bringing together leaders across discovery, engineering, and translation, the summit showcases breakthrough strategies, mechanistic insights, and clinical learnings shaping safer, more potent, and precisely targeted TCEs.
New for this year, two tracks, Discovery & Engineering and Preclinical & Translational, allowing attendees to tailor their experience. Gain fresh clinical insights from Amgen and Regeneron on combination strategies, precision immunotherapy, and innovative TCE designs driving deeper, more durable responses in solid tumours.
